Sections
Nephrology
Biography
Education and Training:
Dr. Ashish Verma earned his medical degree from Government Stanley Medical College in Chennai, India. He completed his internal medicine residency at the University of Tennessee College of Medicine in Chattanooga, followed by a clinical and research fellowship in nephrology at Brigham and Women’s Hospital and Massachusetts General Hospital. During this time, he also held a joint appointment as a Clinical Fellow in Medicine at Harvard Medical School and trained as a research fellow under Dr. Sushrut S. Waikar, focusing on predictors of CKD progression. His work has been supported by an American Heart Association (AHA) Career Development Award.
Academic Leadership & Editorial Roles:
Dr. Verma is a recognized leader in the global nephrology community, contributing to the field's top-tier academic literature. He serves as an Associate Editor for Kidney360 (American Society of Nephrology portfolio). His professional service and recognition include:
American Heart Association: Member of the Kidney in Cardiovascular Medicine Committee.
Framingham Heart Study: Member of the Ancillary Proposals Review Committee.
National Recognition: Named a Top 1% All-Star Nephrology Researcher (2024–2025) by Avant-Garde Health.
Research & Scholarship:
As a clinician-investigator at the Boston University Chobanian & Avedisian School of Medicine, Dr. Verma’s research integrates epidemiology, physiology, and proteomics to uncover pathways of Cardiovascular–Kidney–Metabolic (CKM) syndrome progression. He has authored more than 70 peer-reviewed publications in premier journals, including BMJ, Annals of Internal Medicine, Circulation, JASN, European Heart Journal, and JACC. His 2025 study on long-term risk estimation across CKM stages was selected for the "Best of ASN Journals."
Clinical Expertise & Mentorship:
Clinically, Dr. Verma specializes in chronic kidney disease, acute kidney injury, cardiorenal syndromes, and systemic amyloidosis. As the Lead Nephrologist for the Boston University Amyloidosis Center, he provides multidisciplinary care for patients with complex systemic diseases at Boston Medical Center.
Deeply committed to medical education, Dr. Verma teaches in BU’s Resident Research Course and mentors medical students, residents, and fellows. Under his guidance, his mentees have consistently achieved first-author publications and received national recognition for their research.
Education
Medicine, MBBS, Stanley Medical School
Publications
Claudel SE, Lloyd-Jones DM, Waikar SS, Verma A. Prevalence of Albuminuria Across Cardiovascular-Kidney-Metabolic Phenotypes in the United States. Diabetes Obes Metab. 2026 Feb 26. PMID: 41749339.
Published on 1/25/2026Steinbuch S, de Vos-Hillebrand L, O'Neill-Dee C, Wu I, Steinbuch H, Kulcsár Z, Ranjan A, Verma A, Landsberg J, Dietrich D, Hardin CC, Jain RK, Subudhi S. Comparative Performance of agentic AI and Physicians in Taking Clinical History across Leading Large Language Models (LLMs). medRxiv. 2026 Jan 25. PMID: 41646794.
Published on 1/19/2026Verma A, Upadhyay A. Diabetic kidney disease, biomarkers, and finerenone. Diabetes Obes Metab. 2026 Apr; 28(4):2582-2593. PMID: 41555617.
Published on 1/10/2026Jaworski R, Amodu A, Liu J, Verma A, Palsson R, Stillman IE, Kestenbaum BR, Waikar SS, Srivastava A. The Association of Urine Albumin to Protein Ratio With Kidney Disease Progression. Kidney Med. 2026 Mar; 8(3):101259. PMID: 41767696.
Published on 11/25/2025Claudel SE, Kar D, Majeed A, Burgwinkle PS, Verma A. Assessment and management of albuminuria in adults. BMJ. 2025 Nov 25; 391:e084911. PMID: 41290349.
Published on 10/28/2025Thomas P, Missikpode C, Martinez OG, Verma A, Zhao R, Claudel SE, Schmidt IM, van Raalte DH, Bjornstad P, Layden BT, Lash JP, Waikar SS, Srivastava A. Association of Pancreas Volume With Adverse Clinical Outcomes. J Am Heart Assoc. 2025 Nov 04; 14(21):e042348. PMID: 41147404.
Published on 10/21/2025Zheng Q, Shao J, Teng J, Jin J, Abramov D, Verma A, Xu Y, Zhu Q, Yao J, Lv J, Cai F, Huang P, Zhou H, Zhou J. Frailty and Its Progression With Cardiovascular Disease Risk With Cardiovascular-Kidney-Metabolic Syndrome Stages 1 to 3. JACC Adv. 2025 Oct 21; 4(12):102274. PMID: 41165649.
Published on 10/10/2025Schmidt IM, Verma A, Claudel S, Rosan S, Lu W, Beck LH, Huynh C, Palsson R, Srivastava A, Stillman I, Avillach C, Huber TB, Volpe J, Betanzos CM, Ocana MF, Berasi SP, Fader KA, Hassanein M, Waikar SS. Associations of Podocyte-Derived Protein Biomarkers With Foot Process Effacement and Kidney Histopathologic Lesions in Individuals With Glomerular Disease. Kidney Med. 2025 Dec; 7(12):101144. PMID: 41342046.
Published on 10/9/2025Thomas P, Salud M, Missikpode C, Martinez OG, Verma A, Zhao R, Claudel SE, Schmidt IM, van Raalte DH, Bjornstad P, Layden BT, Lash JP, Waikar SS, Srivastava A. Association of pancreas fat fraction with adverse kidney and cardiovascular outcomes. Clin Kidney J. 2025 Dec; 18(12):sfaf310. PMID: 41404372.
Published on 8/20/2025Joshi T, Prokaeva T, Gopal DM, Verma A, Sanchorawala V, Chen H, Burks E, Dasari S, McPhail ED, Staron A. Wild-Type Transthyretin Amyloidosis in the Kidneys. JACC Case Rep. 2025 Sep 24; 30(29):105132. PMID: 40833310.
Media Mentions
Published on 6/12/2024
Published on 5/21/2024
What is CKM Syndrome? Report Finds Most Americans Meet Criteria For Early Stages
Published on 4/10/2024
Even Normal-Range Albuminuria May Increase Risk of CKD Progression, Kidney Failure
Published on 4/10/2024
Published on 4/4/2024
Patients with CKD and Normoalbuminuria May Have Higher Risk for Disease Progression
Published on 4/2/2024
CKD Progression Risk Up With Increasing Albuminuria in Normal Range
Published on 4/2/2024
CKD Progress Risk Increased Even if Albuminuria Range Normal
Published on 4/1/2024
CKD Progression Risk Up With Increasing Albuminuria in Normal Range
Published on 10/17/2023
What Is CKM Syndrome? American Heart Association Identifies New Medical Condition
Published on 8/10/2022
High Aldosterone Levels Increase Risk for CKD Progression
View full list of 12 media mentions.